Abstract
Motivation Intratumor heterogeneity (ITH) represents the diversity of cell populations that make up cancer tissue. The level of ITH in a tumor is usually measured by a genomic variation profile, such as copy number variation and somatic mutation. However, a recent study has identified ITH at the transcriptome level and suggested that ITH at gene expression levels is useful for predicting prognosis. Measuring ITH levels at the spliceome level is a natural extension. There are serious technical challenges in measuring spliceomic ITH (sITH) from bulk tumor RNA sequencing (RNA-seq) due to the complex splicing patterns. Results We propose an information-theoretic method to measure the sITH of bulk tumors to overcome the above challenges. This method has been extensively tested in experiments using synthetic data, xenograft tumor data, and TCGA pan-cancer data. As a result, we showed that sITH is closely related to cancer progression and clonal heterogeneity, along with clinically significant features such as cancer stage, survival outcome and PAM50 subtype. As far as we know, it is the first study to define ITH at the spliceome level. This method can greatly improve the understanding of cancer spliceome and has great potential as a diagnostic and prognostic tool.
Original language | English |
---|---|
Article number | e0223520 |
Journal | PLoS ONE |
Volume | 14 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2019 |
Externally published | Yes |
Funding
This work was supported by 2014M3C9A3063541, 2017M3C4A7065887, HI15C3224 and 2019M3E5D4065965, National Research Foundation of Korea (https://www.nrf.re. kr/index, authors who received the funding: Minsu, Sangseon, Sangsoo, Sun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funders | Funder number |
---|---|
National Research Foundation of Korea |